Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indoco Remedies has informed the exchanges that its trading window for equity shares will be closed from Wednesday, 1st April 2026 until 48 hours after the declaration of its Audited Standalone and Consolidated Financial Results for Q4 and the full year ended 31st March 2026. The closure is in line with SEBI's Insider Trading Regulations, 2015, and applies to all designated persons of the company along with their immediate relatives, who have been advised not to buy or sell shares during this period. The exact date of the board meeting where the FY26 results will be approved has not yet been announced and will be communicated later. This is a routine compliance disclosure typically filed by companies before quarterly or annual earnings.
No direct impact on shareholders or stock price. The trading window closure is a standard regulatory practice to prevent insider trading ahead of a major results announcement — FY26 audited numbers are expected in the coming weeks.